Companies complying with Abbreviated New Drug Application (ANDA)
An ANDA is a submission to the FDA that provides data for the review and approval of a generic drug, allowing the applicant to manufacture and market a lower‑cost version of a brand‑name product.
1,880
companies
List of companies that comply with Abbreviated New Drug Application (ANDA)
This is sourced from job postings — companies only hire for what they actively use or plan to adopt · how we source this →
| Company | Country | Industry | Employees | Revenue | Technologies |
|---|---|---|---|---|---|
United States | Pharmaceutical Manufacturing | 7.6k | $2.1B | Abbreviated New Drug Application (ANDA) | |
India | Pharmaceutical Manufacturing | 32k | $5.6B | Abbreviated New Drug Application (ANDA) | |
United Kingdom | Pharmaceutical Manufacturing | 11k | $2.3B | Abbreviated New Drug Application (ANDA) | |
India | Pharmaceutical Manufacturing | 33k | Abbreviated New Drug Application (ANDA) | ||
United States | Pharmaceutical Manufacturing | 18k | Abbreviated New Drug Application (ANDA) | ||
United States | Pharmaceutical Manufacturing | 1.1k | Abbreviated New Drug Application (ANDA) | ||
United States | Pharmaceutical Manufacturing | 81 | Abbreviated New Drug Application (ANDA) | ||
Canada | Pharmaceutical Manufacturing | 6.6k | Abbreviated New Drug Application (ANDA) | ||
United States | Pharmaceutical Manufacturing | 53 | Abbreviated New Drug Application (ANDA) | ||
Israel | Pharmaceutical Manufacturing | 30k | $15B | Abbreviated New Drug Application (ANDA) |
Showing top companies out of 1,880 that comply with Abbreviated New Drug Application (ANDA). Get the full list on TheirStack.
Frequently asked questions









